NCT06360523View on ClinicalTrials.gov

To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence

NARecruitingINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

March 31, 2028

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

AI modal

The MRI image will be reviewed by radiologist and AI model(s) respectively. The urologist will combine the results of the two approaches to optimize the biopsy strategy which is expected to result in more accurate diagnosis.

DIAGNOSTIC_TEST

Standard review

The MRI image will be reviewed by radiologist.

Trial Locations (1)

Unknown

RECRUITING

Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER